Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P17
Within normal range
vs 2Y Ago
-4.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-172.35%
2024160.48%
202340.36%
2022-52.51%
2021-161.31%
2020-249.85%
20190.00%